| Name | 7-Xylosyl-10-deacetyltaxol |
|---|---|
| Synonyms |
Paclitaxel Impurity 49
DEACETYL-7-XYLOTAXOL, 10-(P) 10-Deacetylpaclitaxel 7-Xyloside (2α,3β,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,10-dihydroxy-9-oxo-7-(β-D-xylopyranosyloxy)-5,20-epoxytax-11-en-2-yl benzoate Deacetyl-7-Xyloslytaxol, 10 b-(Benzoylamino)-a-hydroxy-benzenepropanoic acid [2-[2aa,4b,4ab,6b,9a*,bS*),11a,12a,12aa,12ba]]-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(b-D-xylopyranosyloxy)-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester 10-Deacetyltaxol 7-xyloside 10-Deacetyl-7-xylosyl paclitaxel, 10 mM in DMSO 7-XYLOXYL-10-DEACETYL TAXOL 7-Xylose-10-deacetyltaxol Paclitaxel Impurity 92 (2α,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,10-dihydroxy-9-oxo-7-(β-D-xylopyranosyloxy)-5,20-epoxytax-11-en-2-yl benzoate 7-XYLOSYL-10-DEACETYLTAXOL benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2,4S,4aS,6R,9S,11S,12S,12,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(β-D-xylopyranosyloxy)-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS) 10-O-Deacetyl-7-O-(beta-xylosyl)paclitaxel 10-O-Deacetyl-7-O-(β-xylosyl)paclitaxel 7-xyloside-10 deacetylpaclitaxel benzenepropanoic acid, b-(benzoylaMino)-a-hydroxy-,(2,4S,4aS,6R,9S,11S,12S,12,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetraMethyl-5-oxo-4-(b-D-xylopyranosyloxy)-7,11-Methano-1H-cyclo 10-Deacetyl-7-xylosyl Paclitaxel Paliperidone Impurity 51 |
| Description | 10-Deacetyl-7-xylosyl paclitaxel is a Paclitaxel derivative with improved pharmacological features and higher water solubility.IC50 value:Target: Microtubule inhibitor10-Deacetyl-7-xylosyl paclitaxel induced mitotic cell cycle arrest and apoptosis as measured by flow cytometry, DNA laddering, and transmission electron microscopy. Pro-apoptotic Bax and Bad protein expression was up-regulated and anti-apoptotic Bcl-2 and Bcl-XL expression down-regulated, which lead to a disturbance of the mitochondrial membrane permeability and to the activation of caspase-9. In turn, caspase-9 activated downstream caspases-3 and -6, but not caspase-8. Bid was also activated by caspase-3. Reversely, treatment with a caspase-10-specific inhibitor could not protect PC-3 cells from 7-xylosyl-10-deacetyl-paclitaxel-triggered apoptosis. Moreover, 7-xylosyl-10-deacetylpaclitaxel had no effect on the expression of CD95 and NF-kappaB proteins, indicating that apoptosis was induced through the mitochondrial-dependent pathway in PC-3 cells. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 1068.4±65.0 °C at 760 mmHg |
| Molecular Formula | C50H57NO17 |
| Molecular Weight | 943.984 |
| Flash Point | 599.9±34.3 °C |
| Exact Mass | 943.362671 |
| PSA | 274.14000 |
| LogP | 7.18 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.660 |
| Storage condition | 2-8℃ |